Danial Medical is a medical device company accredited by the Assistance Publique - Hôpitaux de Paris, developing a centrifugal pump to treat Heart Failure with preserved Ejection Fraction, HFpEF
Heart Failure is a public health problem
No established treatment is available for HFpEF
The pathology is very common worldwide:
The mortality rate is 30% at 1 year and 65% at 5 years.
In France alone, 500,000 patients suffer from HFpEF, a figure that is constantly rising (+1%/year).
It is becoming necessary to develop interventional therapies
Our patented solution
A centrifugal mini-pump for unloading the left heart
size of a pacemaker
Minimally invasive implantation
No risk of stroke or thrombosis
Partners
Team
Samuel Danial
Chief Executive Officer
Pichoy Danial
Cardiac Surgeon, Chief Scientific Officer
News
Danial Medical is awarded several subsidies to help develop its patented solution to treat HFpEF, including awards from BPI and AP-HP Booster Innovation
